Navigation Links
Rcadia Medical Imaging Awarded Four U.S. Patents Covering Technology for Automated Analysis of Coronary CT Angiography
Date:6/28/2011

NEWTON, Mass., June 28, 2011 /PRNewswire/ -- Rcadia Medical Imaging today announced that the company has been granted four patents by the U.S. Patent and Trademark Office covering technology for its COR Analyzer® System.  The COR Analyzer performs fully automatic analysis of Coronary CT Angiography (cCTA) studies to accelerate emergency department triage of suspected coronary artery disease (CAD) patients and optimize cardiology and radiology department workflow. The System is marketed in the U.S. and distributed through an agreement with Siemens Healthcare.

"The COR Analyzer is a powerful decision support tool which has shown great potential in clinical trials and routine use to reduce unnecessary admissions and shorten time to treatment," said Shai Levanon, President and CEO of Rcadia. "The patents strengthen the intellectual property position around this innovative system."  He noted that the COR Analyzer is the first of a new category of software applications to broadly enable the use of advanced imaging technologies in emergency medicine to improve care and reduce costs.

The four patents broadly cover methods and algorithms for automated analysis of coronary CT angiography studies and detection of pathologies in coronary arteries. The patents also cover methods for results visualization and automatic assessment of study quality. In addition, the methods are extended to cover the automatic interpretation of triple rule out studies.

Triage of suspected CAD patients represents a major clinical and healthcare economic challenge in the U.S.  An estimated six million patients enter the ED in the U.S. each year with chest pain. Because current diagnostic techniques are often equivocal, an estimated two million, primarily low risk patients, are admitted to the hospital for further testing at an annual cost of $10-$13 billion. In an estimated 85 percent of these patients, an acute coronary event is subsequently ruled out.

About Rcadia Medical Imaging

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT Angiography to enable the practical application of cCTA in detecting significant coronary artery disease. The COR Analyzer improves the utility of Coronary CTA studies in the emergency department to triage chest pain patients and optimizes work flow in cardiology and radiology departments. Learn more at www.rcadia.com.


'/>"/>
SOURCE Rcadia Medical Imaging Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
4. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
5. Arcadia Resources to Present at Lazard Healthcare Conference in New York
6. Arcadia Resources Names Stephen Goldsmith to Board of Directors
7. Rcadia Medical Imaging’s COR Analyzer(R) System Receives CE Mark
8. Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
9. Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting
10. Arcadian Healths Chief Information Officer to Address Role of CIOs from a Healthcare Perspective at the CIO Executive Leadership Roundtable in Santa Monica
11. Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company ... and market advanced products and therapies for the Wound ... sectors of healthcare, today announced its record results for ... 2016. Full Year 2016 Highlights are: ... full year 2015 revenue ...
(Date:2/23/2017)...   SeraCare Life Sciences , a manufacturer ... manufacturers and clinical laboratories, is announcing an upcoming ... Tests" to be hosted by GenomeWeb ... Standard Time (US). The goal of ... improved performance and global standardization in the implementation ...
(Date:2/23/2017)... , February 23, 2017 The U.S. ... legalized cannabis for recreational use in 2016. According to a ... market was worth an estimated $7.2 billion in 2016 and ... of 17%. While adult recreational sales are projected to jump ... with a 25% CAGR. The market may grow faster as ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... Dr. David Mahon leads Siena Dental, a comprehensive dental ... named a 2017 Top Patient Rated Henderson Dentist by Find Local Doctors ... local physicians and dentists who have earned high ratings and superior patient reviews from ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinical trials, today announced that Premier Research, a leading clinical development service provider, ... trials are becoming increasingly complex, due in part to an array of circumstances ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... publication and community for those in the fight against cancer, has produced a ... their success. HRA will release top-line findings in a webinar, Defining Compassionate ...
(Date:2/23/2017)... VA – , ... ... coming. It’s the perfect opportunity for the nation to come ... a college basketball bracket – with its favorite fruit – ... is encouraging apple lovers to join the “Apple Madness” bracket ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... of her Smiling Patriot program today with a new Indiegogo campaign ... dental care to homeless veterans in the Los Angeles area, either as a participating ...
Breaking Medicine News(10 mins):